InsiderSource
ELVN

Enliven Therapeutics, Inc.

SEC CIK 1672619
$45.33 +62.9% · 90 days
90-day buys
$0
0 open-market
90-day sells
$2.33M
11 open-market
Net insider flow
−$2.33M
Net selling
Filings shown
38
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at ELVN have sold a net $2.33M of stock (0 open-market buys vs 11 sells).

Largest recent trade: Lyssikatos Joseph P sold $1.46M of ELVN, trimming their stake 6%.

Most active filer: Collins Helen Louise, with 19 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for ELVN, newest first
View on SEC EDGAR ↗
Advertisement
ELVN
Enliven Therapeutics, Inc.
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Apr 21, 2026 ΔOwn −8.1%

Collins Helen Louise sold $114.6K of ELVN, trimming their stake 8%.

−$114.6K
2,419 sh @ $47
ELVN
Enliven Therapeutics, Inc.
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Apr 21, 2026 ΔOwn −8.9%

Collins Helen Louise sold $117.3K of ELVN, trimming their stake 9%.

−$117.3K
2,441 sh @ $48
ELVN
Enliven Therapeutics, Inc.
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 27, 2026 ΔOwn −62%

Collins Helen Louise sold $1.4M of ELVN, trimming their stake 62%.

−$1.4M
40,000 sh @ $35
ELVN
Enliven Therapeutics, Inc.
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 19, 2026 ΔOwn −17%

Collins Helen Louise sold $138.8K of ELVN, trimming their stake 17%.

−$138.8K
5,000 sh @ $28
ELVN
Enliven Therapeutics, Inc.
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 11, 2026 ΔOwn −29%

Collins Helen Louise sold $305.8K of ELVN, trimming their stake 29%.

−$305.8K
10,129 sh @ $30
ELVN
Enliven Therapeutics, Inc.
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Mar 11, 2026 ΔOwn −54%

Collins Helen Louise sold $896.8K of ELVN, trimming their stake 54%.

−$896.8K
29,871 sh @ $30
ELVN
Enliven Therapeutics, Inc.
Sell Hohl Benjamin · CHIEF FINANCIAL OFFICER · Open-market sale · filed Mar 10, 2026 ΔOwn −16%

Hohl Benjamin sold $295.8K of ELVN, trimming their stake 16%.

−$295.8K
10,000 sh @ $30
ELVN
Enliven Therapeutics, Inc.
Sell Collins Helen Louise · CHIEF MEDICAL OFFICER · Open-market sale · filed Feb 19, 2026 ΔOwn −64%

Collins Helen Louise sold $1.18M of ELVN, trimming their stake 64%.

−$1.18M
45,000 sh @ $26
ELVN
Enliven Therapeutics, Inc.
Sell Lyssikatos Joseph P · CHIEF SCIENTIFIC OFFICER · Open-market sale · filed Feb 10, 2026 ΔOwn −0.7%

Lyssikatos Joseph P sold $145.2K of ELVN, trimming their stake 1%.

−$145.2K
5,000 sh @ $29
ELVN
Enliven Therapeutics, Inc.
Sell Lyssikatos Joseph P · CHIEF SCIENTIFIC OFFICER · Open-market sale · filed Jan 22, 2026 ΔOwn −0.7%

Lyssikatos Joseph P sold $144.8K of ELVN, trimming their stake 1%.

−$144.8K
5,491 sh @ $26
ELVN
Enliven Therapeutics, Inc.
Sell Lyssikatos Joseph P · CHIEF SCIENTIFIC OFFICER · Open-market sale · filed Jan 22, 2026 ΔOwn −1.9%

Lyssikatos Joseph P sold $390.3K of ELVN, trimming their stake 2%.

−$390.3K
14,509 sh @ $27
Advertisement

About ELVN insider activity

This page tracks every recent Form 4 filed for Enliven Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ELVN insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Enliven Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.